Urgent Call to Mpox Vaccine Makers: Submit Your Emergency Dossiers Now!

N-Ninja
2 Min Read

WHO Calls for ‍Mpox Vaccine Proposals to Address⁢ Emerging Health Concerns

The World Health Organization (WHO) ​has formally‌ reached out to manufacturers ⁣of emergency-declaration/” title=”Growing Mpox Outbreak Sparks Urgent WHO Discussions on Global Emergency Declaration”>mpox⁤ vaccines, inviting them to present an Expression ‌of Interest for Emergency Use Listing (EUL).

On August 7,​ 2024, the Director-General of WHO highlighted pressing concerns regarding the escalating spread of mpox. A particularly alarming outbreak ‍has been ‍reported in the Democratic Republic of the Congo (DRC), which has begun ‌to extend beyond its borders. Moreover, a novel viral strain that originated in September 2023 has now been identified outside DRC ⁢for the first time.

Understanding Emergency Use Listing Procedures

The​ EUL is a specialized process designed to fast-track access to unlicensed medical products—including vaccines—required during public health emergencies. This temporary authorization takes into account a thorough analysis of risks versus benefits.

WHO‍ is urging vaccine developers to provide comprehensive data that ensures their products meet safety and effectiveness standards while maintaining high-quality assurance suitable⁢ for targeted demographics.

Facilitating ​Rapid Access for Vulnerable Populations

By granting an EUL,‌ organizations can expedite access to vaccines—particularly benefiting lower-income nations that have not⁤ yet established their own national‍ regulatory approvals. Additionally, this mechanism allows ⁤partners like Gavi and ⁤UNICEF to ⁤procure these vaccines more efficiently for widespread distribution.

What Is Mpox? Understanding Its Transmission Routes

Mpox is caused by the monkeypox virus belonging to the Orthopoxvirus genus.⁤ The disease can be transmitted through direct contact with infected individuals, contaminated materials, or animals carrying the virus.

Currently, there are two approved vaccines available⁢ against mpox; ⁣both have received recommendations from WHO’s Strategic Advisory Group of Experts on Immunization (SAGE).

For further details about‍ this initiative and related⁣ developments, please refer to⁣ this source.

Share This Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *